MannKind | MNKD - Interest Expense On Debt

Stock Price
2.77
Daily Change
-0.01 -0.18%
Monthly
-50.09%
Yearly
-47.23%
Q1 Forecast
2.69

MannKind reported $13.87M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Adma Biologics USD 1.68M 150K Sep/2025
BioCryst Pharmaceuticals USD 14.14M 5.53M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Halozyme Therapeutics USD 4.91M 615K Dec/2025
Insmed USD 20.6M 217K Dec/2025
Karyopharm Therapeutics USD 11.38M 2.43M Sep/2024
MacroGenics USD 3.34M 2.54M Sep/2025
MannKind USD 13.87M 6.54M Dec/2025
Merck USD 412M 85M Dec/2025
Minerva Neurosciences USD 2.31M 60K Jun/2024
Novavax USD 5.82M 342K Dec/2025
Pfizer USD 711M 59M Dec/2025
Sanofi EUR -25M 252M Dec/2025
Xencor USD 7.35M 311K Dec/2025